Kelia Leach

Kelia Leach is a Director of Pharmacovigilance Risk Management (Rare Disease) at Amgen, where they lead global risk management strategies and the preparation of risk management plans. With over 17 years of experience in the pharmaceutical biotech industry, Kelia has a strong background in pharmacovigilance, project management, and process improvement. They have previously held key roles at companies such as Horizon and AveXis, where they contributed significantly to safety and risk management initiatives. Kelia earned an Associate of Science in Registered Nursing from Western Kentucky University and a Bachelor of Science in Health Care Administration from National Louis University.